Comments
Sun Pharma Advanced Research Company (SPARC) has received an order from the Office of the Commissioner of GST & Central Excise demanding payment of service tax along with penalty and interest aggregating to ₹46.04 crore. However, the company will contest the demand and file an appeal against the order within the stipulated time, it said in a notice to the stock exchanges. Shareholders of SPARC will closely monitor the development.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.